中文版PROMIS疼痛干扰简表在肿瘤患者中的测量学检验  

The psychometric test of Chinese version-PROMIS pain interference short form among patients with cancer

作　　者：黄跃师 袁长蓉 杨瑒 张雯 蔡婷婷 吴傅蕾 黄青梅 张雯 张乃立 张晓菊 HUANG Yueshi;YUAN Changrong;YANG Yang;ZHANG Wen;CAI Tingting;WU Fulei;HUANG Qingmei;ZHANG Wen;ZHANG Naili;ZHANG Xiaoju(Department of Nursing,Fudan University Shanghai Cancer Center&Department of Oncology,Shanghai Medical College,Fudan University,Shanghai 200032,China;School of Nursing,Fudan University,Shanghai 200032,China)

机构地区：[1]复旦大学附属肿瘤医院护理部复旦大学上海医学院肿瘤学系,上海200032 [2]复旦大学护理学院,上海200032

出　　处：《护士进修杂志》2024年第20期2233-2237,共5页Journal of Nurses Training

基　　金：国家自然科学基金项目(编号:71874032);复旦复星护理科研基金项目(编号:FNF201812)。

摘　　要：目的在肿瘤患者群体中评价中文版患者报告结局测量信息系统(patient-reported outcomes measurement information system,PROMIS)疼痛干扰4a简表的测量学指标。方法于2021年12月-2022年1月,使用PROMIS疼痛干扰4a简表在复旦大学附属肿瘤医院采用方便抽样法调研收集肿瘤患者资料,采用Mplus 8.3软件及SPSS 20.0软件分析量表及条目的地板效应、天花板效应;分析量表的结构效度、效标关联效度和信度等测量性能;并初步进行量表的测量等价性检验。结果最终纳入240例肿瘤患者。中文版PROMIS疼痛干扰4a简表在肿瘤患者群体中的Cronbach′sα系数为0.961,信度较好。验证性因子分析提示模型拟合较好。量表评分与中文版欧洲癌症研究中心(EORTC)生命品质评估量表(Quality of life questionnaire.core 30,QLO-C30)(v3.0)疼痛维度呈显著正相关(P<0.01),效标关联效度较好。癌症早期和晚期患者疼痛干扰得分差异具有统计学意义(P<0.05),提示已知组别效度良好。量表条目评分最低1分的患者比例大于20%,提示存在明显的地板效应。结论中文版PROMIS疼痛干扰4a简表在肿瘤患者中的测量学性能总体较好,适用于国内肿瘤患者人群。但今后还需对部分性能进一步检验和调试。Objective To evaluate the psychometric properties of Chinese version-patient-reported outcomes measurement information system(PROMIS)pain interference short form 4a among patients with cancer.Methods The data of cancer patients in the Fudan University Shanghai Cancer Center was collected by PROMIS pain interference short form,and Mplus 8.3 software and SPSS 20.0 software were used to analyze the floor effect and ceiling effect of the scales and items,and to measure the structure validity,criterion association validity,and reliability of the scale,and the measurement equivalence was preliminarily evaluated.Results A total of 240 cancer patients were finally comprised for data analysis.The Cronbach'sαcoefficient of the Chinese version-PROMIS pain interference short form was 0.961 in patients with cancer,indicating good reliability.The results of confirmatory factor analysis suggested that the model fitted well.There was a significant positive correlation between the short form and the Chinese version-EORTC QLQ-C30(v3.0)pain dimension(P<0.01),indicating good concurrent validity.The difference of pain interference score between early and later cancer patients was statistically significant(P<0.05),suggesting good known-groups validity.The proportion of patients with the lowest item score of 1 in the scale was greater than 20%,indicating the existence of significant floor effect.Conclusions The Chinese version-PROMIS pain interference short form 4a has good overall measurement performance in cancer patients,and is suitable for domestic cancer patients.However,it is necessary to further test and debug some performance in the future.

关 键 词：癌症 患者报告结局 疼痛干扰 测量学检验 

分 类 号：R473.73[医药卫生—护理学]